Indonesia International Institute for Life Sciences - Learning Resources Center

  • Home
  • Information
  • News
  • Help
  • Librarian
  • Member Area
  • Select Language :
    Arabic Bengali Brazilian Portuguese English Espanol German Indonesian Japanese Malay Persian Russian Thai Turkish Urdu

Search by :

ALL Author Subject ISBN/ISSN Advanced Search

Last search:

{{tmpObj[k].text}}
No image available for this title
Bookmark Share

Thesis

Optimization Of Liquid Chromatography Analycal Method For Quanficaon Of Erythropoien Aggregate At PT. Kalbio Global Medika

Vania Gisela - Personal Name;

Erythropoietin is a glycoprotein hormone produced by the kidney. Erythropoietin is a
hormone that controls the production of erythrocytic progenitors. Since 1989, erythropoietin (EPO)
has been used to treat anemia-related diseases. The formulation of the EPO product was altered in
2004. The occurrence of creutzfeldt-jakob disease (CJD) led to the replacement of the stabilizer,
human serum albumin (HSA), with polysorbate 80. The recipe was also altered in order to gain a
halal label for distribution in Muslim nations. Changes in the formulation were discovered to cause
pure red cell aplasia (PRCA). The PRCA was speculated to occur as a result of an aggregation in the
pharmaceutical products. PT. Kalbio Global Medika used liquid chromatography (ultra performance
liquid chromatography and high performance liquid chromatography) to detect the aggregate of
EPO protein. The ultra high performance liquid chromatography equipment was used in conjunction
with a reverse phase column, whereas the high performance liquid chromatography instrument was
used in conjunction with a size exclusion column. This study concluded that the size exclusion HPLC
gave better results in detecting EPO aggregate than the reverse phase UPLC. The size exclusion
HPLC chromatogram result shows the EPO aggregate peak that was separated from the EPO peak.
In size exclusion HPLC, the aggregate peak result can be quantified, but in reverse phase UPLC, the
aggregate peak was not separated from the EPO peak, making quantification more challenging. The
prevalidation method was done after choosing the best liquid chromatography method.
Prevalidation was conducted to ensure that the method can be utilized for various EPO and the
aggregate separation and detection. The prevalidation using size exclusion HPLC was determined
successful since all the trial results were within the acceptance criteria.


Availability
#
My Library (BT Thesis) BT 23-025
T202306025
Available
Detail Information
Series Title
-
Call Number
BT 23-025
Publisher
i3L, Jakarta : i3L, Jakarta., 2023
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Liquid chromatography
rythropoietin (EPO)
Pure Red Cell Aplasia
Prevalidation
Specific Detail Info
-
Statement of Responsibility
-
Other version/related

No other version available

File Attachment
No Data
Comments

You must be logged in to post a comment

Indonesia International Institute for Life Sciences - Learning Resources Center
  • Information
  • Services
  • Librarian
  • Member Area

About Us

i3L Learning Resources Center (LRC) is vital part of your academic experience at Indonesia International Institute for Life-Sciences. LRC exists to support the teaching, learning and research programs of the Institute through the provision of high quality services and facilities which include access to a range of printed and digital resources primarily in the field of life-sciences and business. 

Search

start it by typing one or more keywords for title, author or subject

Keep SLiMS Alive Want to Contribute?

© 2025 — Senayan Developer Community

Powered by SLiMS
Select the topic you are interested in
  • Computer Science, Information & General Works
  • Philosophy & Psychology
  • Religion
  • Social Sciences
  • Language
  • Pure Science
  • Applied Sciences
  • Art & Recreation
  • Literature
  • History & Geography
Icons made by Freepik from www.flaticon.com
Advanced Search
Where do you want to share?